SCHEMBL5334361

http://dbpedia.org/resource/SCHEMBL5334361 an entity of type: Thing

SCHEMBL5334361 is a drug which acts as an agonist at the 5-HT2 family of serotonin receptors, and was developed for the treatment of glaucoma. It is a benzazepine derivative structurally related to the anorectic drug lorcaserin. It is selective for 5-HT2A, with an EC50 of 0.4nM at 5-HT2A vs 3.9nM at 5-HT2C and a much lower affinity of 417nM at 5-HT2B. rdf:langString

rdfs:label

rdf:langString SCHEMBL5334361

foaf:name

rdf:langString SCHEMBL5334361

dbpedia-owl:wikiPageID

xsd:integer 70031804

dbpedia-owl:wikiPageRevisionID

xsd:integer 1087771324

dbpprop:c

xsd:integer 18

dbpprop:casNumber

xsd:integer 959867

dbpprop:drugName

rdf:langString SCHEMBL5334361

dbpprop:h

xsd:integer 21

dbpprop:iupacName

xsd:integer 7

dbpprop:n

xsd:integer 1

dbpprop:o

xsd:integer 2

dbpprop:pubchem

xsd:integer 59027940

dbpprop:smiles

rdf:langString COC1=CCOCC2=CC3=CC=C2

dbpprop:stdinchi

xsd:integer 1

dbpprop:stdinchikey

rdf:langString BFCIUKMUJQOSDE-UHFFFAOYSA-N

dbpedia-owl:abstract

rdf:langString SCHEMBL5334361 is a drug which acts as an agonist at the 5-HT2 family of serotonin receptors, and was developed for the treatment of glaucoma. It is a benzazepine derivative structurally related to the anorectic drug lorcaserin. It is selective for 5-HT2A, with an EC50 of 0.4nM at 5-HT2A vs 3.9nM at 5-HT2C and a much lower affinity of 417nM at 5-HT2B.

dbpedia-owl:wikiPageLength

xsd:nonNegativeInteger 1702

dbpedia-owl:casNumber

xsd:string 959867-47-1

dbpedia-owl:pubchem

xsd:string 59027940

rdf:type

owl:Thing

<http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject>

dbpedia-owl:ChemicalSubstance

<http://www.wikidata.org/entity/Q8386>

dbpedia-owl:Drug